Morphic to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference
June 18, 2020 08:00 ET
|
Morphic Therapeutic
WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...